Cosmetic Outcome of Electrocautery, Scalpel and PEAK PlasmaBlade for Surgical Breast Incisions

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
AgeNot listed
SponsorUniversity of British Columbia

About this trial

This study will compare the cosmetic scar result from the use of scalpel, electrocautery, and pulsed electron avalanche knife (PEAK) PlasmaBlade (PPB) for the initial skin incision for total mastectomy procedures without immediate breast reconstruction.

It is hypothesized that there will be no significant difference in mastectomy scar cosmesis.

The purpose and objectives of this study are:

1. To evaluate and compare the cosmetic scar result from the use of scalpel, standard electrocautery, or PEAK PlasmaBlade for initial incision for total mastectomy procedures without immediate breast reconstruction. 2. To inform future equipment choices for breast surgery including potential elimination of scalpels and their attendant risks.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patients having a total mastectomy with or without axilla surgical staging

Disqualifiers

Patients having immediate breast reconstruction

Patients with a diagnosis of inflammatory breast cancer

History of keloid scar formation

History of connective tissue disorder (scleroderma or rheumatoid arthritis with skin involvement)

Trial design

Design model

Parallel

Treatments tested in this trial

  • Scalpel and standard electrocautery or PEAK PlasmaBlade

    Device

    Scalpel followed by completion of surgery with standard electrocautery or PEAK PlasmaBlade.

  • PEAK PlasmaBlade

    Device

    PEAK PlasmaBlade for entire surgery.

  • Standard Electrocautery

    Device

    Standard Electrocautery for entire surgery.

Treatment groups

186 Participants
are divided into 3 treatment groups
Group A: Standard of CareActive comparator 1 intervention
Group B: PEAK PlasmaBladeExperimental treatment 1 intervention
Group C: Standard ElectrocauteryExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Scar cosmesis (SCAR scale)

Mastectomy site scar cosmesis will be evaluated 2-4 weeks post-operatively by two independent observers blinded to the equipment used for the surgery using photo evaluation with the Scar Cosmesis Assessment and Rating (SCAR) scale. The SCAR scale yields scores ranging from a minimum score of 0 (best possible scar) to a maximum score of 15 (worst possible scar).

Time frame
2-4 weeks post-operatively
2

Scar cosmesis (Vancouver Scar Scale)

Mastectomy site scar cosmesis will be evaluated 2-4 weeks post-operatively by the treating surgeon using the Vancouver Scar Scale for physical examination. The Vancouver Scar Scale yields scores ranging from 0 (best) to 13 (worst).

Time frame
2-4 weeks post-operatively
3

Scar cosmesis (SCAR-Q)

Patient reported outcomes will be reported 2-4 weeks post-operatively using the SCAR-Q scale, a comprehensive scar appearance scale with independently functioning domains for scar appearance, scar symptoms and psychosocial impact, which each yield transformed scores ranging from 0 (worst) to 100 (best).

Time frame
2-4 weeks post-operatively
4

Scar cosmesis (SCAR scale)

Mastectomy site scar cosmesis will be evaluated 6 months post-operatively by two independent observers blinded to the equipment used for the surgery using photo evaluation with the Scar Cosmesis Assessment and Rating (SCAR) scale. The SCAR scale yields scores ranging from a minimum score of 0 (best possible scar) to a maximum score of 15 (worst possible scar).

Time frame
6 months post-operatively

Secondary outcomes

1

Development of post-operative seroma

Development of post-operative seroma, graded using the Clavien-Dindo classification system for surgical complications. The Clavien-Dindo classification of surgical complications ranges from Grade I (any deviation from the normal postoperative course without the need for pharmacological treatment or surgical, endoscopic, and radiological interventions) to Grade V (death of a patient).

Time frame
within 12 months post-operatively
2

Development of post-operative hematoma

Development of post-operative hematoma, graded using the Clavien-Dindo classification system for surgical complications. The Clavien-Dindo classification of surgical complications ranges from Grade I (any deviation from the normal postoperative course without the need for pharmacological treatment or surgical, endoscopic, and radiological interventions) to Grade V (death of a patient).

Time frame
within 12 months post-operatively
3

Development of excessive bruising

Development of post-operative excessive bruising, graded using the Clavien-Dindo classification system for surgical complications. The Clavien-Dindo classification of surgical complications ranges from Grade I (any deviation from the normal postoperative course without the need for pharmacological treatment or surgical, endoscopic, and radiological interventions) to Grade V (death of a patient).

Time frame
within 12 months post-operatively
4

Development of flap necrosis

Development of post-operative flap-necrosis, graded using the Clavien-Dindo classification system for surgical complications. The Clavien-Dindo classification of surgical complications ranges from Grade I (any deviation from the normal postoperative course without the need for pharmacological treatment or surgical, endoscopic, and radiological interventions) to Grade V (death of a patient).

Time frame
within 12 months post-operatively

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.